微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 4.32% | 0.02% | -61.28% | 13/69 | 2.26% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 11.15% | -16.29% | 10.95% | 15/69 | 3.28% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 10.05% | -10.51% | 36.55% | 18/69 | 3.08% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 7.36% | -7.3% | 70.53% | 14/69 | 0.67% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 4.32% | -0.55% | -67.6% | 14/69 | 1.53% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 13.32% | 6.73% | 18.61% | 14/69 | 0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 11.23% | 23.95% | 41.44% | 16/69 | 7.26% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 7.94% | 19.22% | 82.95% | 13/69 | 4.93% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 4.34% | 17.62% | -65.22% | 17/69 | 3.21% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 12.48% | 5.49% | 37.75% | 18/69 | 6.65% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 9.06% | 0.11% | 36.04% | 22/69 | 5.16% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 6.66% | 9.54% | 80.49% | 17/69 | 3.2% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 3.69% | 15.67% | -68.81% | 13/69 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 11.83% | 11.5% | 30.72% | 19/69 | 4.54% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 9.05% | 19.71% | 48.85% | 25/69 | 7.54% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 6.08% | 21.12% | 90.6% | 20/69 | 4.68% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 3.19% | 25.1% | -69.93% | 19/69 | 2.7% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 10.61% | 9.49% | 40.34% | 21/69 | 0.1% | *ST长药 | 7.37% | 行业排名> |
| 2020-09-30 | 7.56% | -13.7% | 50.6% | 30/69 | 6.79% | 沃华医药 | 22.84% | 行业排名> |
| 2020-06-30 | 5.02% | -26.5% | 96.86% | 22/69 | 3.75% | 沃华医药 | 19.47% | 行业排名> |
| 2020-03-31 | 2.55% | -31.27% | -73.68% | 22/69 | 2.14% | 沃华医药 | 12.7% | 行业排名> |
| 2019-12-31 | 9.69% | -14.47% | 10.62% | 30/69 | 5.86% | 济川药业 | 7.33% | 行业排名> |
| 2019-09-30 | 8.76% | -9.69% | 28.26% | 24/69 | 7.3% | 济川药业 | 27.43% | 行业排名> |
| 2019-06-30 | 6.83% | -6.18% | 84.1% | 17/69 | 4.72% | 济川药业 | 23.05% | 行业排名> |
| 2019-03-31 | 3.71% | 0.27% | -67.26% | 18/69 | 2.92% | 济川药业 | 15.79% | 行业排名> |
| 2018-12-31 | 11.33% | -8.11% | 16.8% | 24/69 | 7.87% | 华润三九 | 10.23% | 行业排名> |
| 2018-09-30 | 9.7% | -4.43% | 33.24% | 21/69 | 8.02% | 济川药业 | 32.79% | 行业排名> |
| 2018-06-30 | 7.28% | -1.22% | 96.76% | 18/69 | 5.03% | 济川药业 | 27.55% | 行业排名> |
| 2018-03-31 | 3.7% | 0% | -69.99% | 20/69 | 2.75% | 济川药业 | 17.62% | 行业排名> |
| 2017-12-31 | 12.33% | 0.98% | 21.48% | 21/69 | 9.93% | 济川药业 | 10.07% | 行业排名> |
| 2017-09-30 | 10.15% | 0.59% | 37.72% | 21/69 | 8.39% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-06-30 | 7.37% | -1.6% | 99.19% | 19/69 | 5.24% | 济川药业 | 24.2% | 行业排名> |
| 2017-03-31 | 3.7% | 2.21% | -69.7% | 19/69 | 2.62% | *ST大药 | 15.31% | 行业排名> |
| 2016-12-31 | 12.21% | -7.57% | 21.01% | 26/69 | 10.02% | 济川药业 | 14.64% | 行业排名> |
| 2016-09-30 | 10.09% | -2.61% | 34.71% | 22/69 | 9.32% | 济川药业 | 7.64% | 行业排名> |
| 2016-06-30 | 7.49% | -4.1% | 106.91% | 20/69 | 5.04% | 维康药业 | 38.23% | 行业排名> |
| 2016-03-31 | 3.62% | -14.82% | -72.6% | 23/69 | 4.1% | 太极集团 | 58.41% | 行业排名> |
| 2015-12-31 | 13.21% | -6.58% | 27.51% | 32/69 | 11.34% | 新光药业 | 16.54% | 行业排名> |
| 2015-09-30 | 10.36% | -6.67% | 32.65% | 25/69 | 8.44% | 太极集团 | 71.6% | 行业排名> |
| 2015-06-30 | 7.81% | -2.25% | 83.76% | 19/69 | 5.48% | 维康药业 | 48.67% | 行业排名> |
| 2015-03-31 | 4.25% | 3.41% | -69.94% | 14/69 | 2.9% | 济川药业 | 21.37% | 行业排名> |